Thioester derivatives of the natural product psammaplin A as potent histone deacetylase inhibitors

Scholarly Works

• Habazaki, M.; Mizumoto, S.; Kajino, H.; Kujirai, T.; Kurumizaka, H.; Kawashima, S. A.; Yamatsugu, K.; Kanai, M. A chemical catalyst enabling histone acylation with endogenous acyl-CoA. Nature communications 2023, 14, 5790. doi:10.1038/s41467-023-41426-z
• Wahi, A.; Jain, P.; Sinhari, A.; Jadhav, H. R. Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents. Naunyn-Schmiedeberg's archives of pharmacology 2023, 397, 675–702. doi:10.1007/s00210-023-02674-4
• Zou, S.; Li, X.; Huang, Y.; Zhang, B.; Tang, H.; Xue, Y.; Zheng, Y. Properties and biotechnological applications of microbial deacetylase. Applied microbiology and biotechnology 2023, 107, 4697–4716. doi:10.1007/s00253-023-12613-1
• Qiu, X.; Zhu, L.; Wang, H.; Tan, Y.; Yang, Z.; Yang, L.; Wan, L. From natural products to HDAC inhibitors: An overview of drug discovery and design strategy. Bioorganic & medicinal chemistry 2021, 52, 116510. doi:10.1016/j.bmc.2021.116510
• Maemoto, Y.; Shimizu, Y.; Katoh, R.; Ito, A. Naturally occurring small molecule compounds that target histone deacetylases and their potential applications in cancer therapy. The Journal of antibiotics 2021, 74, 667–676. doi:10.1038/s41429-021-00459-6
• M, S. L. K.; Ali, K.; Chaturvedi, P.; Meena, S.; Datta, D.; Panda, G. Design, synthesis and biological evaluation of oxime lacking Psammaplin inspired chemical libraries as anti-cancer agents. Journal of Molecular Structure 2021, 1225, 129173. doi:10.1016/j.molstruc.2020.129173
• Conte, M.; Fontana, E.; Nebbioso, A.; Altucci, L. Marine-Derived Secondary Metabolites as Promising Epigenetic Bio-Compounds for Anticancer Therapy. Marine drugs 2020, 19, 15. doi:10.3390/md19010015
• Kim, Y.; Song, K. H.; Lee, S. Synthesis of S-aryl thioesters via palladium-catalyzed thiocarbonylation of aryl iodides and aryl sulfonyl hydrazides. Organic Chemistry Frontiers 2020, 7, 2938–2943. doi:10.1039/d0qo00748j
• Cappellacci, L.; Perinelli, D. R.; Maggi, F.; Grifantini, M.; Petrelli, R. Recent Progress in Histone Deacetylase Inhibitors as Anticancer Agents. Current medicinal chemistry 2020, 27, 2449–2493. doi:10.2174/0929867325666181016163110
• Abbass, S. A.; Hassan, H. A.; Mohamed, M. F.; Moustafa, G. A. I.; Abuo-Rahma, G. E.-D. A.
• Jing, Q.; Hu, X.; Ma, Y.; Mu, J.; Liu, W.; Xu, F.; Li, Z.-L.; Bai, J.; Hua, H.-M.; Li, D. Marine-Derived Natural Lead Compound Disulfide-Linked Dimer Psammaplin A: Biological Activity and Structural Modification. Marine drugs 2019, 17, 384. doi:10.3390/md17070384
• Zhang, Q.; Lv, J.; He, F.; Yu, C.; Qu, Y.; Zhang, X.; Xu, A.; Wu, J. Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors. Bioorganic & medicinal chemistry 2019, 27, 1595–1604. doi:10.1016/j.bmc.2019.03.008
• Ratovitski, E. A. Anticancer Natural Compounds as Epigenetic Modulators of Gene Expression. Current genomics 2017, 18, 175–205. doi:10.2174/1389202917666160803165229
• Weston, C. E.; Krämer, A.; Colin, F.; Yildiz, Ö.; Baud, M. G. J.; Meyer-Almes, F.-J.; Fuchter, M. J. Toward Photopharmacological Antimicrobial Chemotherapy Using Photoswitchable Amidohydrolase Inhibitors. ACS infectious diseases 2016, 3, 152–161. doi:10.1021/acsinfecdis.6b00148
• Al Mamun Bhuyan, A.; Signoretto, E.; Lang, F. Triggering of Suicidal Erythrocyte Death by Psammaplin A. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2016, 39, 908–918. doi:10.1159/000447800
• Florean, C.; Schnekenburger, M.; Lee, J. Y.; Kim, K. R.; Mazumder, A.; Song, S.; Kim, J.-M.; Grandjenette, C.; Kim, J.-G.; Yoon, A.-Y.; Dicato, M.; Kim, K.-W.; Christov, C.; Han, B. W.; Proksch, P.; Diederich, M. Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cells. Oncotarget 2016, 7, 24027–24049. doi:10.18632/oncotarget.8210
• Uesato, S.; Matsuura, Y.; Matsue, S.; Sumiyoshi, T.; Hirata, Y.; Takemoto, S.; Kawaratani, Y.; Yamai, Y.-s.; Ishida, K.; Sasaki, T.; Enari, M. Discovery of new low-molecular-weight p53–Mdmx disruptors and their anti-cancer activities. Bioorganic & medicinal chemistry 2016, 24, 1919–1926. doi:10.1016/j.bmc.2016.03.021
• Wen, J.; Bao, Y.; Niu, Q.; Liu, J.; Yang, J.; Wang, W.-Q.; Jiang, T.; Fan, Y.; Li, K.; Wang, J.; Zhao, L.; Liu, D. Synthesis, biological evaluation and molecular modeling studies of psammaplin A and its analogs as potent histone deacetylases inhibitors and cytotoxic agents. Bioorganic & medicinal chemistry letters 2015, 26, 4372–4376. doi:10.1016/j.bmcl.2015.12.094
• Hong, S.; Shin, Y.; Jung, M.; Ha, M. W.; Park, Y.; Lee, Y.-J.; Shin, J.; Oh, K.-B.; Lee, S. K.; Park, H.-g. Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents. European journal of medicinal chemistry 2015, 96, 218–230. doi:10.1016/j.ejmech.2015.04.001
• Mottamal, M.; Zheng, S.; Huang, T. L.; Wang, G. Histone deacetylase inhibitors in clinical studies as templates for new anticancer agents. Molecules (Basel, Switzerland) 2015, 20, 3898–3941. doi:10.3390/molecules20033898

Explore citations to this article at